Glottal characteristics of female speakers: Acoustic correlates
HM Hanson - The Journal of the Acoustical Society of America, 1997 - pubs.aip.org
The aim of the research reported in this paper is to formulate a set of acoustic parameters of
the voicing source that reflect individual differences in the voice qualities of female speakers. …
the voicing source that reflect individual differences in the voice qualities of female speakers. …
Glottal characteristics of male speakers: Acoustic correlates and comparison with female data
HM Hanson, ES Chuang - The Journal of the Acoustical Society of …, 1999 - pubs.aip.org
… speakers Hanson, … work Hanson, 1995a, 1997 to include male speakers. Acoustic data
were collected from 21 males, interpreted in terms of the theoretical models presented in Hanson …
were collected from 21 males, interpreted in terms of the theoretical models presented in Hanson …
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
…, E Hahnen, U Hamann, H Hanson… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide precise age-specific risk estimates of cancers other than female breast
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
[HTML][HTML] Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
…, Z Kemp, M Gore, A Strydom, S Banerjee, H Hanson… - Scientific reports, 2016 - nature.com
Advances in DNA sequencing have made genetic testing fast and affordable, but limitations
of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies …
of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies …
[HTML][HTML] Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
BRCA1 and BRCA2 gene pathogenic variants account for most hereditary breast cancer and
are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of BRCA-…
are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of BRCA-…
[HTML][HTML] Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
Background Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-…
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-…
Towards models of phonation
HM Hanson, KN Stevens, HKJ Kuo, MY Chen… - Journal of …, 2001 - Elsevier
The earliest models of phonation were based on the assumption that the glottis is closed
during a part of the vibration cycle, that is, the phonation is modal. Nonmodal phonation, …
during a part of the vibration cycle, that is, the phonation is modal. Nonmodal phonation, …
Effects of obstruent consonants on fundamental frequency at vowel onset in English
HM Hanson - The Journal of the Acoustical Society of America, 2009 - pubs.aip.org
When a vowel follows an obstruent, the fundamental frequency in the first few tens of milliseconds
of the vowel is known to be influenced by the voicing characteristics of the consonant. …
of the vowel is known to be influenced by the voicing characteristics of the consonant. …
Development and testing of a portable vocal accumulator
HA Cheyne, HM Hanson, RP Genereux, KN Stevens… - 2003 - ASHA
This research note describes the design and testing of a device for unobtrusive, long-term
ambulatory monitoring of voice use, named the Portable Vocal Accumulator (PVA). The PVA …
ambulatory monitoring of voice use, named the Portable Vocal Accumulator (PVA). The PVA …
[HTML][HTML] Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
…, E Hahnen, U Hamann, H Hanson… - Genetics in …, 2020 - nature.com
Purpose We assessed the associations between population-based polygenic risk scores (PRS)
for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and …
for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and …